| Q35074415 | A leptin-sympathetic-leptin feedback loop: potential implications for regulation of arterial pressure and body fat. |
| Q38020317 | A sympathetic view of human obesity |
| Q40693524 | Abnormalities of autonomic nervous control in human hypertension |
| Q37419996 | Blood pressure regulation VIII: resistance vessel tone and implications for a pro-atherogenic conduit artery endothelial cell phenotype |
| Q36652535 | Cardiovascular risk factors in perspective |
| Q89274867 | Carotid Artery Stiffness and Development of Hypertension in People with Paraplegia and No Overt Cardiovascular Disease: A 7-year Follow-up Study |
| Q34450600 | Cholesterol screening in a community health promotion program: epidemiologic results from a biracial population |
| Q26748721 | Clinical assessment of hypertension in children |
| Q36167904 | Clinical trials and clinical practice in the elderly. A focus on hypertension |
| Q40626764 | Clinical uses of ambulatory blood pressure monitoring |
| Q74798319 | Control of risk factors in peripheral vascular disease. Management of hypertension |
| Q51291016 | Effects of antihypertensive drugs losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension combined with isolated impaired fasting glucose. |
| Q51580159 | Elevation of plasminogen activator inhibitor 1 in borderline hypertension is linked to concomitant metabolic disturbances. |
| Q47180534 | Heritability of left atrial size in the Tecumseh population |
| Q51600901 | Hyperinsulinemia in hypertension: increased secretion, reduced clearance or both? |
| Q36218894 | Hypertension in diabetics registered in primary health care centers in makkah district, saudi arabia |
| Q71009098 | Hypertension in pediatric patients |
| Q80051577 | Lipoprotein lipase gene is in linkage with blood pressure phenotypes in Chinese pedigrees |
| Q33743188 | Obesity and hypertension |
| Q37262225 | Prehypertension: risk stratification and management considerations |
| Q34706868 | Report of the Canadian Hypertension Society Consensus Conference: 2. Diagnosis of hypertension in adults |
| Q36149676 | Risk of progression to hypertension in a low-income Mexican population with prehypertension and normal blood pressure |
| Q37499184 | Risk stratification by self-measured home blood pressure across categories of conventional blood pressure: a participant-level meta-analysis |
| Q33786237 | Screening for cardiovascular disease. Concepts, conflicts, and consensus |
| Q43272246 | Seasonal variation in haemodynamics and blood pressure-regulating hormones |
| Q36829019 | Should the results of TROPHY affect the JNC 7 definition of prehypertension? |
| Q34317621 | Statins and blood pressure regulation. |
| Q37156484 | The DASH Diet and Insulin Sensitivity |
| Q44115081 | The impact of the components of metabolic syndrome on heart rate variability: using the NCEP-ATP III and IDF definitions. |
| Q37739848 | The prognostic significance of heart rate for cardiovascular disease and hypertension |
| Q38099744 | The reason why home blood pressure measurements are preferred over clinic or ambulatory blood pressure in Japan. |
| Q34981000 | The role of cardiac autonomic function in hypertension and cardiovascular disease |
| Q79218631 | Treatment of prehypertension: how soon is soon enough? What therapy should be used? |
| Q57150824 | What are the public health implications of subclinical depressive symptoms? |
| Q40387998 | White coat hypertension and related phenomena. A clinical approach. |